<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36233180</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>19</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>06</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Mitochondrial and Endoplasmic Reticulum Alterations in a Case of Amyotrophic Lateral Sclerosis Caused by TDP-43 A382T Mutation.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">11881</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms231911881</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis is the most common form of motor neuron disease. Mutations in <i>TARDBP</i>, the gene encoding the RNA-binding protein TDP-43, are responsible for about 5% of familial ALS. Here we report the clinical and biological features of an ALS patients with pA382T mutation in TPD-43 protein. Disease began with right hand muscles weakness, and equally involved upper and lower motor neuron with a classic phenotype, without cognitive impairment. While a family history of neurological diseases was reported, there was no evidence of familial frontotemporal dementia. Cultured fibroblasts from the patient were characterized by profound alterations of cell proteome, which impacts particularly the mitochondrial metabolic pathways and the endoplasmic reticulum. TDP-43 levels were similar to control, healthy fibroblasts, but a higher fraction localized in mitochondria. Mitochondrial network appeared fragmented, and the organelles smaller and more spheric. In agreement with impaired proteome and morphology of mitochondria, basal cell respiration was reduced. Mitochondrial DNA levels appeared normal. However, a higher amount of mitochondrial DNA was present in the cytosol, suggesting a pronounced mitochondrial DNA misplacement which can promote a pro-inflammatory response mediating by cGAS/STING. Thus, this case report further expands the clinical and pathological phenotype of A382T mutation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zanini</LastName><ForeName>Giada</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Life Sciences, University of Modena and Reggio Emilia, Via G. Campi 287, 41125 Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Selleri</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Life Sciences, University of Modena and Reggio Emilia, Via G. Campi 287, 41125 Modena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute for Cardiovascular Research, Via Irnerio 28, 40126 Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nasi</LastName><ForeName>Milena</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3079-8001</Identifier><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, 41125 Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Gaetano</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Life Sciences, University of Modena and Reggio Emilia, Via G. Campi 287, 41125 Modena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute for Cardiovascular Research, Via Irnerio 28, 40126 Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinelli</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Biomedical, Metabolic and Neurosciences, University of Modena and Reggio Emilia, Via G. Campi 287, 41125 Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gianferrari</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-4260-0915</Identifier><AffiliationInfo><Affiliation>Department of Biomedical, Metabolic and Neurosciences, University of Modena and Reggio Emilia, Via G. Campi 287, 41125 Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lofaro</LastName><ForeName>Francesco Demetrio</ForeName><Initials>FD</Initials><AffiliationInfo><Affiliation>Department of Life Sciences, University of Modena and Reggio Emilia, Via G. Campi 287, 41125 Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boraldi</LastName><ForeName>Federica</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-0277-9017</Identifier><AffiliationInfo><Affiliation>Department of Life Sciences, University of Modena and Reggio Emilia, Via G. Campi 287, 41125 Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mandrioli</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-9244-9782</Identifier><AffiliationInfo><Affiliation>Department of Biomedical, Metabolic and Neurosciences, University of Modena and Reggio Emilia, Via G. Campi 287, 41125 Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinti</LastName><ForeName>Marcello</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9118-1262</Identifier><AffiliationInfo><Affiliation>Department of Life Sciences, University of Modena and Reggio Emilia, Via G. Campi 287, 41125 Modena, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2016-02364678</GrantID><Agency>Italian Medicines Agency</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004272">DNA, Mitochondrial</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020543">Proteome</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.-</RegistryNumber><NameOfSubstance UI="D009713">Nucleotidyltransferases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004272" MajorTopicYN="N">DNA, Mitochondrial</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004721" MajorTopicYN="N">Endoplasmic Reticulum</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009713" MajorTopicYN="N">Nucleotidyltransferases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020543" MajorTopicYN="N">Proteome</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">mitochondria</Keyword><Keyword MajorTopicYN="N">mtDNA</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>14</Day><Hour>2</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36233180</ArticleId><ArticleId IdType="pmc">PMC9570187</ArticleId><ArticleId IdType="doi">10.3390/ijms231911881</ArticleId><ArticleId IdType="pii">ijms231911881</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrado L., Ratti A., Gellera C., Buratti E., Castellotti B., Carlomagno Y., Ticozzi N., Mazzini L., Testa L., Taroni F., et al. High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis. Hum. Mutat. 2009;30:688&#x2013;694. doi: 10.1002/humu.20950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.20950</ArticleId><ArticleId IdType="pubmed">19224587</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesiridis G.S., Lee V.M., Trojanowski J.Q. Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis. Hum. Mol. Genet. 2009;18:R156&#x2013;R162. doi: 10.1093/hmg/ddp303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp303</ArticleId><ArticleId IdType="pmc">PMC2758707</ArticleId><ArticleId IdType="pubmed">19808791</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood A., Gurfinkel Y., Polain N., Lamont W., Lyn Rea S. Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD. Int. J. Mol. Sci. 2021;22:4705. doi: 10.3390/ijms22094705.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22094705</ArticleId><ArticleId IdType="pmc">PMC8125728</ArticleId><ArticleId IdType="pubmed">33946763</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P., Valdmanis P., Millecamps S., Lionnet C., Blasco H., Mouzat K., Daoud H., Belzil V., Morales R., Pageot N., et al. Phenotype and genotype analysis in amyotrophic lateral sclerosis with TARDBP gene mutations. Neurology. 2012;78:1519&#x2013;1526. doi: 10.1212/WNL.0b013e3182553c88.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182553c88</ArticleId><ArticleId IdType="pubmed">22539580</ArticleId></ArticleIdList></Reference><Reference><Citation>Gianferrari G., Martinelli I., Zucchi E., Simonini C., Fini N., Vinceti M., Ferro S., Gessani A., Canali E., Valzania F., et al. Epidemiological, Clinical and Genetic Features of ALS in the Last Decade: A Prospective Population-Based Study in the Emilia Romagna Region of Italy. Biomedicines. 2022;10:819. doi: 10.3390/biomedicines10040819.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10040819</ArticleId><ArticleId IdType="pmc">PMC9031824</ArticleId><ArticleId IdType="pubmed">35453569</ArticleId></ArticleIdList></Reference><Reference><Citation>Benajiba L., Le Ber I., Camuzat A., Lacoste M., Thomas-Anterion C., Couratier P., Legallic S., Salachas F., Hannequin D., Decousus M., et al. TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration. Ann. Neurol. 2009;65:470&#x2013;473. doi: 10.1002/ana.21612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21612</ArticleId><ArticleId IdType="pubmed">19350673</ArticleId></ArticleIdList></Reference><Reference><Citation>Borghero G., Pugliatti M., Marrosu F., Marrosu M.G., Murru M.R., Floris G., Cannas A., Parish L.D., Occhineri P., Cau T.B., et al. Genetic architecture of ALS in Sardinia. Neurobiol. Aging. 2014;35:2882.e7&#x2013;2882.e12. doi: 10.1016/j.neurobiolaging.2014.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.07.012</ArticleId><ArticleId IdType="pmc">PMC4252367</ArticleId><ArticleId IdType="pubmed">25123918</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A., Borghero G., Pugliatti M., Ticca A., Calvo A., Moglia C., Mutani R., Brunetti M., Ossola I., Marrosu M.G., et al. Large proportion of amyotrophic lateral sclerosis cases in Sardinia due to a single founder mutation of the TARDBP gene. Arch. Neurol. 2011;68:594&#x2013;598. doi: 10.1001/archneurol.2010.352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2010.352</ArticleId><ArticleId IdType="pmc">PMC3513278</ArticleId><ArticleId IdType="pubmed">21220647</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannas A., Borghero G., Floris G.L., Solla P., Chio A., Traynor B.J., Calvo A., Restagno G., Majounie E., Costantino E., et al. The p.A382T TARDBP gene mutation in Sardinian patients affected by Parkinson&#x2019;s disease and other degenerative parkinsonisms. Neurogenetics. 2013;14:161&#x2013;166. doi: 10.1007/s10048-013-0360-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-013-0360-2</ArticleId><ArticleId IdType="pmc">PMC3661017</ArticleId><ArticleId IdType="pubmed">23546887</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe S., Kaneko K., Yamanaka K. Accelerated disease onset with stabilized familial amyotrophic lateral sclerosis (ALS)-linked mutant TDP-43 proteins. J. Biol. Chem. 2013;288:3641&#x2013;3654. doi: 10.1074/jbc.M112.433615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.433615</ArticleId><ArticleId IdType="pmc">PMC3561582</ArticleId><ArticleId IdType="pubmed">23235148</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai T.H., Choi M., Banfai B., Liu Y., MacLean B.X., Dunkley T., Vitek O. Selection of Features with Consistent Profiles Improves Relative Protein Quantification in Mass Spectrometry Experiments. Mol. Cell Proteom. 2020;19:944&#x2013;959. doi: 10.1074/mcp.RA119.001792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.RA119.001792</ArticleId><ArticleId IdType="pmc">PMC7261813</ArticleId><ArticleId IdType="pubmed">32234965</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng W., Wang S., Zhang Z., Morgens D.W., Hayes L.R., Lee S., Portz B., Xie Y., Nguyen B.V., Haney M.S., et al. CRISPR-Cas9 Screens Identify the RNA Helicase DDX3X as a Repressor of C9ORF72 (GGGGCC)n Repeat-Associated Non-AUG Translation. Neuron. 2019;104:885&#x2013;898.e8. doi: 10.1016/j.neuron.2019.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.09.003</ArticleId><ArticleId IdType="pmc">PMC6895427</ArticleId><ArticleId IdType="pubmed">31587919</ArticleId></ArticleIdList></Reference><Reference><Citation>Theunissen F., West P.K., Brennan S., Petrovic B., Hooshmand K., Akkari P.A., Keon M., Guennewig B. New perspectives on cytoskeletal dysregulation and mitochondrial mislocalization in amyotrophic lateral sclerosis. Transl. Neurodegener. 2021;10:46. doi: 10.1186/s40035-021-00272-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-021-00272-z</ArticleId><ArticleId IdType="pmc">PMC8597313</ArticleId><ArticleId IdType="pubmed">34789332</ArticleId></ArticleIdList></Reference><Reference><Citation>Suk T.R., Rousseaux M.W.C. The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. Mol. Neurodegener. 2020;15:45. doi: 10.1186/s13024-020-00397-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00397-1</ArticleId><ArticleId IdType="pmc">PMC7429473</ArticleId><ArticleId IdType="pubmed">32799899</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Lin L., Tradewell M.L., Dion P.A., Bercier V., Bourgouin P., Rochefort D., Bel Hadj S., Durham H.D., Vande Velde C., et al. Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. Hum. Mol. Genet. 2010;19:671&#x2013;683. doi: 10.1093/hmg/ddp534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp534</ArticleId><ArticleId IdType="pubmed">19959528</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrioli J., Mediani L., Alberti S., Carra S. ALS and FTD: Where RNA metabolism meets protein quality control. Semin. Cell Dev. Biol. 2020;99:183&#x2013;192. doi: 10.1016/j.semcdb.2019.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2019.06.003</ArticleId><ArticleId IdType="pubmed">31254610</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannini M., Bayona-Feliu A., Sproviero D., Barroso S.I., Cereda C., Aguilera A. TDP-43 mutations link Amyotrophic Lateral Sclerosis with R-loop homeostasis and R loop-mediated DNA damage. PLoS Genet. 2020;16:e1009260. doi: 10.1371/journal.pgen.1009260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1009260</ArticleId><ArticleId IdType="pmc">PMC7755276</ArticleId><ArticleId IdType="pubmed">33301444</ArticleId></ArticleIdList></Reference><Reference><Citation>Orru S., Coni P., Floris A., Littera R., Carcassi C., Sogos V., Brancia C. Reduced stress granule formation and cell death in fibroblasts with the A382T mutation of TARDBP gene: Evidence for loss of TDP-43 nuclear function. Hum. Mol. Genet. 2016;25:4473&#x2013;4483. doi: 10.1093/hmg/ddw276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw276</ArticleId><ArticleId IdType="pubmed">28172957</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutihac R., Alegre-Abarrategui J., Gordon D., Farrimond L., Yamasaki-Mann M., Talbot K., Wade-Martins R. TARDBP pathogenic mutations increase cytoplasmic translocation of TDP-43 and cause reduction of endoplasmic reticulum Ca(2)(+) signaling in motor neurons. Neurobiol. Dis. 2015;75:64&#x2013;77. doi: 10.1016/j.nbd.2014.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.12.010</ArticleId><ArticleId IdType="pubmed">25526708</ArticleId></ArticleIdList></Reference><Reference><Citation>Onesto E., Colombrita C., Gumina V., Borghi M.O., Dusi S., Doretti A., Fagiolari G., Invernizzi F., Moggio M., Tiranti V., et al. Gene-specific mitochondria dysfunctions in human TARDBP and C9ORF72 fibroblasts. Acta Neuropathol. Commun. 2016;4:47. doi: 10.1186/s40478-016-0316-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0316-5</ArticleId><ArticleId IdType="pmc">PMC4858818</ArticleId><ArticleId IdType="pubmed">27151080</ArticleId></ArticleIdList></Reference><Reference><Citation>De Marco G., Lomartire A., Calvo A., Risso A., De Luca E., Mostert M., Mandrioli J., Caponnetto C., Borghero G., Manera U., et al. Monocytes of patients with amyotrophic lateral sclerosis linked to gene mutations display altered TDP-43 subcellular distribution. Neuropathol. Appl. Neurobiol. 2017;43:133&#x2013;153. doi: 10.1111/nan.12328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12328</ArticleId><ArticleId IdType="pubmed">27178390</ArticleId></ArticleIdList></Reference><Reference><Citation>Borghero G., Floris G., Cannas A., Marrosu M.G., Murru M.R., Costantino E., Parish L.D., Pugliatti M., Ticca A., Traynor B.J., et al. A patient carrying a homozygous p.A382T TARDBP missense mutation shows a syndrome including ALS, extrapyramidal symptoms, and FTD. Neurobiol. Aging. 2011;32:2327.e1&#x2013;2327.e5. doi: 10.1016/j.neurobiolaging.2011.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.06.009</ArticleId><ArticleId IdType="pmc">PMC3192246</ArticleId><ArticleId IdType="pubmed">21803454</ArticleId></ArticleIdList></Reference><Reference><Citation>Goris A., van Setten J., Diekstra F., Ripke S., Patsopoulos N.A., Sawcer S.J., International Multiple Sclerosis Genetics Consortium. van Es M., Australia and New Zealand MS Genetics Consortium. Andersen P.M., et al. No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis. Hum. Mol. Genet. 2014;23:1916&#x2013;1922. doi: 10.1093/hmg/ddt574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt574</ArticleId><ArticleId IdType="pmc">PMC3943520</ArticleId><ArticleId IdType="pubmed">24234648</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui C., Longinetti E., Larsson H., Andersson J., Pawitan Y., Piehl F., Fang F. Associations between autoimmune diseases and amyotrophic lateral sclerosis: A register-based study. Amyotroph. Lateral Scler. Frontotemporal Degener. 2021;22:211&#x2013;219. doi: 10.1080/21678421.2020.1861022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1861022</ArticleId><ArticleId IdType="pubmed">33331190</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Goldacre R., Ramagopalan S., Talbot K., Goldacre M.J. Autoimmune disease preceding amyotrophic lateral sclerosis: An epidemiologic study. Neurology. 2013;81:1222&#x2013;1225. doi: 10.1212/WNL.0b013e3182a6cc13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182a6cc13</ArticleId><ArticleId IdType="pmc">PMC3795611</ArticleId><ArticleId IdType="pubmed">23946298</ArticleId></ArticleIdList></Reference><Reference><Citation>Etemadifar M., Abtahi S.H., Akbari M., Maghzi A.H. Multiple sclerosis and amyotrophic lateral sclerosis: Is there a link? Mult. Scler. 2012;18:902&#x2013;904. doi: 10.1177/1352458511427719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458511427719</ArticleId><ArticleId IdType="pubmed">22146612</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemminki K., Li X., Sundquist J., Sundquist K. Familial risks for amyotrophic lateral sclerosis and autoimmune diseases. Neurogenetics. 2009;10:111&#x2013;116. doi: 10.1007/s10048-008-0164-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-008-0164-y</ArticleId><ArticleId IdType="pubmed">19089474</ArticleId></ArticleIdList></Reference><Reference><Citation>Longinetti E., Sveinsson O., Press R., Ye W., Ingre C., Piehl F., Fang F. ALS patients with concurrent neuroinflammatory disorders; a nationwide clinical records study. Amyotroph. Lateral Scler. Frontotemporal Degener. 2022;23:209&#x2013;219. doi: 10.1080/21678421.2021.1946084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2021.1946084</ArticleId><ArticleId IdType="pubmed">34852680</ArticleId></ArticleIdList></Reference><Reference><Citation>Francois-Moutal L., Perez-Miller S., Scott D.D., Miranda V.G., Mollasalehi N., Khanna M. Structural Insights Into TDP-43 and Effects of Post-translational Modifications. Front. Mol. Neurosci. 2019;12:301. doi: 10.3389/fnmol.2019.00301.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00301</ArticleId><ArticleId IdType="pmc">PMC6934062</ArticleId><ArticleId IdType="pubmed">31920533</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Wang L., Lu J., Siedlak S.L., Fujioka H., Liang J., Jiang S., Ma X., Jiang Z., da Rocha E.L., et al. The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nat. Med. 2016;22:869&#x2013;878. doi: 10.1038/nm.4130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4130</ArticleId><ArticleId IdType="pmc">PMC4974139</ArticleId><ArticleId IdType="pubmed">27348499</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartolome F., Wu H.C., Burchell V.S., Preza E., Wray S., Mahoney C.J., Fox N.C., Calvo A., Canosa A., Moglia C., et al. Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels. Neuron. 2013;78:57&#x2013;64. doi: 10.1016/j.neuron.2013.02.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.02.028</ArticleId><ArticleId IdType="pmc">PMC3843114</ArticleId><ArticleId IdType="pubmed">23498975</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozzo F., Mirra A., Carri M.T. Oxidative stress and mitochondrial damage in the pathogenesis of ALS: New perspectives. Neurosci. Lett. 2017;636:3&#x2013;8. doi: 10.1016/j.neulet.2016.04.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2016.04.065</ArticleId><ArticleId IdType="pubmed">27150074</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Amico E., Factor-Litvak P., Santella R.M., Mitsumoto H. Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis. Free Radic. Biol. Med. 2013;65:509&#x2013;527. doi: 10.1016/j.freeradbiomed.2013.06.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2013.06.029</ArticleId><ArticleId IdType="pmc">PMC3859834</ArticleId><ArticleId IdType="pubmed">23797033</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu C.H., Davidson S., Harapas C.R., Hilton J.B., Mlodzianoski M.J., Laohamonthonkul P., Louis C., Low R.R.J., Moecking J., De Nardo D., et al. TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. Cell. 2020;183:636&#x2013;649.e18. doi: 10.1016/j.cell.2020.09.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.020</ArticleId><ArticleId IdType="pmc">PMC7599077</ArticleId><ArticleId IdType="pubmed">33031745</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibellini L., Pinti M., Boraldi F., Giorgio V., Bernardi P., Bartolomeo R., Nasi M., De Biasi S., Missiroli S., Carnevale G., et al. Silencing of mitochondrial Lon protease deeply impairs mitochondrial proteome and function in colon cancer cells. FASEB J. 2014;28:5122&#x2013;5135. doi: 10.1096/fj.14-255869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.14-255869</ArticleId><ArticleId IdType="pubmed">25154874</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T., Lu B., Lee I., Ondrovicova G., Kutejova E., Suzuki C.K. DNA and RNA binding by the mitochondrial lon protease is regulated by nucleotide and protein substrate. J. Biol. Chem. 2004;279:13902&#x2013;13910. doi: 10.1074/jbc.M309642200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M309642200</ArticleId><ArticleId IdType="pubmed">14739292</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu B., Yadav S., Shah P.G., Liu T., Tian B., Pukszta S., Villaluna N., Kutejova E., Newlon C.S., Santos J.H., et al. Roles for the human ATP-dependent Lon protease in mitochondrial DNA maintenance. J. Biol. Chem. 2007;282:17363&#x2013;17374. doi: 10.1074/jbc.M611540200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M611540200</ArticleId><ArticleId IdType="pubmed">17420247</ArticleId></ArticleIdList></Reference><Reference><Citation>Lofaro F.D., Boraldi F., Garcia-Fernandez M., Estrella L., Valdivielso P., Quaglino D. Relationship Between Mitochondrial Structure and Bioenergetics in Pseudoxanthoma elasticum Dermal Fibroblasts. Front. Cell Dev. Biol. 2020;8:610266. doi: 10.3389/fcell.2020.610266.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.610266</ArticleId><ArticleId IdType="pmc">PMC7773789</ArticleId><ArticleId IdType="pubmed">33392199</ArticleId></ArticleIdList></Reference><Reference><Citation>Lofaro F.D., Cisterna B., Lacavalla M.A., Boschi F., Malatesta M., Quaglino D., Zancanaro C., Boraldi F. Age-Related Changes in the Matrisome of the Mouse Skeletal Muscle. Int. J. Mol. Sci. 2021;22:564. doi: 10.3390/ijms221910564.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms221910564</ArticleId><ArticleId IdType="pmc">PMC8508832</ArticleId><ArticleId IdType="pubmed">34638903</ArticleId></ArticleIdList></Reference><Reference><Citation>Rath S., Sharma R., Gupta R., Ast T., Chan C., Durham T.J., Goodman R.P., Grabarek Z., Haas M.E., Hung W.H.W., et al. MitoCarta3.0: An updated mitochondrial proteome now with sub-organelle localization and pathway annotations. Nucleic Acids Res. 2021;49:D1541&#x2013;D1547. doi: 10.1093/nar/gkaa1011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa1011</ArticleId><ArticleId IdType="pmc">PMC7778944</ArticleId><ArticleId IdType="pubmed">33174596</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Zhou B., Pache L., Chang M., Khodabakhshi A.H., Tanaseichuk O., Benner C., Chanda S.K. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 2019;10:1523. doi: 10.1038/s41467-019-09234-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09234-6</ArticleId><ArticleId IdType="pmc">PMC6447622</ArticleId><ArticleId IdType="pubmed">30944313</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibellini L., Losi L., De Biasi S., Nasi M., Lo Tartaro D., Pecorini S., Patergnani S., Pinton P., De Gaetano A., Carnevale G., et al. LonP1 Differently Modulates Mitochondrial Function and Bioenergetics of Primary Versus Metastatic Colon Cancer Cells. Front. Oncol. 2018;8:254. doi: 10.3389/fonc.2018.00254.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2018.00254</ArticleId><ArticleId IdType="pmc">PMC6046640</ArticleId><ArticleId IdType="pubmed">30038898</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibellini L., Pinti M., Beretti F., Pierri C.L., Onofrio A., Riccio M., Carnevale G., De Biasi S., Nasi M., Torelli F., et al. Sirtuin 3 interacts with Lon protease and regulates its acetylation status. Mitochondrion. 2014;18:76&#x2013;81. doi: 10.1016/j.mito.2014.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2014.08.001</ArticleId><ArticleId IdType="pubmed">25128872</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhry A., Shi R., Luciani D.S. A pipeline for multidimensional confocal analysis of mitochondrial morphology, function, and dynamics in pancreatic beta-cells. Am. J. Physiol. Endocrinol. Metab. 2020;318:E87&#x2013;E101. doi: 10.1152/ajpendo.00457.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.00457.2019</ArticleId><ArticleId IdType="pmc">PMC7052579</ArticleId><ArticleId IdType="pubmed">31846372</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasi M., Bianchini E., De Biasi S., Gibellini L., Neroni A., Mattioli M., Pinti M., Iannone A., Mattioli A.V., Simone A.M., et al. Increased plasma levels of mitochondrial DNA and pro-inflammatory cytokines in patients with progressive multiple sclerosis. J. Neuroimmunol. 2020;338:577107. doi: 10.1016/j.jneuroim.2019.577107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2019.577107</ArticleId><ArticleId IdType="pubmed">31726376</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>